TL;DR
This study reveals that chronic stress (CUMS) leads to a significant imbalance in the gut microbiota, specifically an overgrowth of butyric acid (BA)-producing bacteria. This leads to an overload of BA in the ileum, which in turn damages the intestinal barrier and is linked to depression-like behaviors.
What Problem Does This Paper Address?
Chronic unpredictable mild stress (CUMS) is a significant contributor to various physical and mental health issues, including digestive disorders and depression. While it's known that CUMS can impair the intestinal mucosal barrier, the precise mechanisms driving this damage remain unclear. Existing research has yielded conflicting results regarding the impact of CUMS on the gut microbiota and intestinal health, highlighting the need for a more detailed, time-course investigation to unravel these complex interactions. This paper aims to bridge this knowledge gap by exploring how CUMS affects the ileal mucosal barrier, the gut microbiota composition, and their metabolic functions over different stress durations.
Methods
The researchers employed a multi-faceted approach to investigate the effects of CUMS on mice:
- CUMS Model: Male C57BL/6 mice were subjected to CUMS for 14, 28, and 42 days, with control groups receiving no stress.
- Behavioral Assessments: Standard tests like the sucrose preference test (SPT), open field test (OFT), tail suspension test (TST), and forced-swim test (FST) were used to evaluate depression-like behaviors.
- Physiological and Biochemical Analysis: Body weight, food intake, organ indices, serum inflammatory markers (TNF-α, IL-1β, IL-6, IL-10), diamine oxidase (DAO), and lipopolysaccharide (LPS) were measured.
- Histopathology: Ileal tissue was analyzed using H&E staining to assess structural damage, villus height, crypt depth, and goblet cell counts.
- Immunohistochemistry (IHC): Protein expression of key intestinal barrier components (occludin, ZO-1, Muc2) and intestinal stem cell markers (Olfm4+) was evaluated.
- Gut Microbiota Analysis: 16S rDNA sequencing was used to analyze the diversity and composition of the ileal microbiota. PICRUSt was employed for predictive functional analysis of microbial metabolism.
- Metabolite Analysis: Free amino acids (FAAs) and short-chain fatty acids (SCFAs), particularly butyric acid (BA), were quantified in ileal contents using liquid chromatography and GC-MS.
- Correlation Analysis: Pearson's correlation was used to identify associations between gut microbiota, metabolites, and intestinal barrier integrity.
- In Vitro Culture: Ileal microbiota from CUMS and control mice were cultured to validate findings regarding BA production and FAA consumption.
Datasets
Not discussed in the paper.
Key Insights and Ideas
- Time-Dependent Impact: The study highlights that the effects of CUMS on the gut and intestinal barrier are not static but evolve over time, with the late stage (42 days) showing the most severe damage.
- Butyric Acid Paradox: While BA is generally beneficial for the gut, this study demonstrates that an overload of BA in the ileum, driven by specific gut bacteria, can be detrimental.
- Microbiota-Metabolite-Barrier Axis: The research establishes a clear link between CUMS, specific gut bacteria (like Muribaculaceae, Ruminococcus, Butyricicoccus), excessive BA production, depletion of certain amino acids, and subsequent ileal mucosal barrier damage.
- Intestinal Stem Cell Inhibition: The study suggests that excessive BA may inhibit the proliferation of intestinal stem cells (ISCs), which are crucial for maintaining gut health, thereby contributing to barrier dysfunction.
- Dysbiosis as a Driver: The observed changes in the gut microbiota composition, with an increase in BA-producing bacteria and a decrease in bacteria sensitive to BA or reliant on specific amino acids, are identified as a key driver of the observed pathology.
Key Results
- Depression-like Behavior: CUMS induced depression-like behaviors in mice, particularly in the early (14 d) and late (42 d) stages.
- Ileal Mucosal Barrier Damage (IMBD): IMBD progressively worsened with the duration of CUMS, with severe damage observed at 42 d, characterized by reduced villus height, increased injury scores, and elevated DAO and LPS levels.
- Butyric Acid Overload: In the late stage (42 d), ileal lumen BA levels were significantly increased and positively correlated with IMBD.
- Microbiota Shift: The abundance of BA-producing bacteria (Muribaculaceae, Ruminococcus, Butyricicoccus) significantly increased in the 42 d CUMS group, while beneficial bacteria (Prevotella, Lactobacillus, Turicibacter, Blautia, Barnesiella) decreased.
- Amino Acid Depletion: In the late stage, key amino acids like aspartic acid, glutamic acid, alanine, and glycine were significantly decreased in the ileal lumen, negatively correlating with BA levels.
- In Vitro Validation: In vitro cultures of ileal microbiota from CUMS mice replicated the in vivo findings, showing increased BA production and FAA consumption.
Limitations and Future Work
- Sex Differences: The study exclusively used male mice, and the authors acknowledge that future research should investigate potential sex-specific effects.
- Complexity of Interactions: The gut microbiota-amino acid metabolism-BA axis is complex, involving multiple interactions. Further in vitro studies are needed to fully elucidate these mechanisms.
- Causality Confirmation: While strong correlations were found, future work should involve ileal microbiota transplantation experiments in germ-free mice to definitively confirm the causal role of specific bacteria in BA accumulation.
- ISC Regulation: The precise relationship between BA enrichment and the regulation of intestinal stem cell proliferation and differentiation remains unclear and warrants further investigation.
- Broader Microbiota Impact: The study focused on specific marker bacteria; further research is needed to understand the broader impact of these changes on the entire ileal microbial community.
Summary updated